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The Other Breast: Indications for Biopsy and/or Mastectomy!
Charles S. Rogers, M D "

A search for malignant and premalignant lesions in 162
contralateral
biopsy and/or
mastectomy
specimens
yielded 45 (27.8%,) malignancies and 54 (33%) premalignant lesions (atypical epithelial hyperplasia, Wel lings
grades III and IV). In those with no palpable or mammographic suspicion of malignancy, the cancer incidence
was 73.8%. Eight malignancies occurred one month to
three years after antecedent biopsies which revealed
premalignant lesions. No cancer has been detected after
biopsies which revealed hyperplasia of grade II or less.
Cancer size at time of discovery varied significantly
with
the method of detection: average 2.7 cm by palpation;
1.6 cm by mammography;
0.5 cm by biopsy. Axillary

metastasis was present in 30%, 20%, and 70%, respectively. Axillary metastasis from occult contralateral cancer
occurred in three instances where none was found from
ipsilateral, clinically evident cancers; synchronous in
two; asynchronous in one by eight years. In a subgroup
ofone hundred prophylactic biopsies performed by the
author, patients with Wolfe P2-DY patterns (vs. N1-P1)
had a high incidence of malignancy (20%, vs. 72.5%) and
af a younger age (average; 53 vs. 73 years). Routine
contralateral biopsy synchronous with ipsilateral mastectomy is recommended.
Patients with
contralateral
severe epithelial atypia should have the option of prophylactic
mastectomy.

Breast cancer is frequently a multicentric and bilateral
disease. Clinically, these characteristics may be absent or
obscure but readily apparent to those w h o study serial
sections of whole breast specimens (1-3). A segmental
resection may remove only a small part of the disease,
and even a radical mastectomy leaves 50% of the target
tissue at risk. If, like the t h y r o i d , the breast(s) had a small
strip of tissue between the two lobes, it w o u l d be considered one organ rather than two.

ble in size explains, in part, why so many " i n t e r v a l "
cancers are detected by patients between annual physical a n d / o r mammographic examinations. Except for
data f r o m the Breast Cancer Detection Demonstration
Projects (BCDDP), scant evidence exists that we are
detecting breast cancer earlier (7). Until we discover
better early detection methods, most w o m e n w h o
develop breast cancer will eventually die f r o m it (8). A
reduction in mortality may require a more aggressive
use of biopsies in those at k n o w n high risk. We need to
know if, and how often, this aggressive approach would
detect lesions significantly earlier—and if the benefits
exceed the risk. Additionally, we need to know how
often, and under what circumstances, epithelial atypia
proceeds to invasive malignancy. O n e such clue may be
the demonstration that some epithelial hyperplasias can
stimulate neovascularity (5).

Malignancy begins at the same time or asynchronously
in multiple terminal ductal lobular units (TDLU) and
evolves f r o m epithelial hyperplasia, to anaplasia, to in
situ carcinoma, and finally to invasive malignancy (1).
The time interval from hyperplasia to in situ malignancy
is u n k n o w n , but studies of growth rates indicate that
invasive breast cancers, on the average, double in
volume in one hundred days (4-5). At this growth rate, it
takes six to eight years for one cancer cell to become one
billion cells in a mass 1.0 cm in diameter, but only
another three hundred days before it grows to eight
billion cells in a 2.0 cm mass.

This communication reports an analysis of 162 consecutive biopsies a n d / o r mastectomies in a group of 450
patients w h o had known cancer in one breast.
tThis paper was presented at the H e n r y Ford Hospital 1982 A l u m n i R e u n i o n o n
O c t o b e r 21-23,1982.

Despite this long latency p e r i o d , we are able to detect
less than 10% of breast cancers while they are still smaller
t h a n l . O c m a n d less than 3% while they are still noninvasive (6). The short interval required for a cancer to d o u -
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Materials and Methods

axillary metastasis from occult cancers in the contralateral breast: synchronous in two cases and asynchronous
(eight years) in one case.

We analyzed 162 consecutive contralateral biopsies
a n d / o r mastectomies (in a group of 450 patients at risk)
at Bay Medical Center between January 1977 through
August 1982. Indications f o r t h e procedures varied with
the individual surgeon and with time. Specimen size
varied f r o m minimal biopsies to the entire breast. Most
biopsies consisted of a full thickness segment of breast
tissue, about one half of a quadrant, or the subareolar
segment. In the absence of palpable abnormalities, the
location of prominent ducts, dysplasias, and asymmetries indicated by mammograms was used to determine
where to perform the biopsy.

During this study, one in situ and seven invasive cancers
have been discovered following 61 antecedent biopsies
that revealed moderate or severe epithelial atypia. Thus
far, no contralateral malignancy has been detected in
patients in w h o m the highest grade of epithelial hyperplasia in a biopsy specimen was Wellings grade II or less.
This is consistent with evidence that severe epithelial
atypia in abnormal terminal ductal lobular units is,
indeed, preneoplastic (1,2).
In a series of one hundred consecutive prophylactic
biopsies performed by the author as a subgroup in this
study, patients with prominent ducts (Wolfe P2 pattern)
or generalized coalescent dysplasia (Wolfe DY) had a
higher incidence of contralateral invasive cancers and
severe epithelial hyperplasia than those with N1-P1 patterns (Table II). These results are consistent with those of
Wellings and Wolfe (9), w h o reported that xeroradiographic and histological risk grades correlate closely. In
biopsies of breasts without malignancy, the highest
grades of precancerous epithelial abnormality were
f o u n d in those with P2 and DV patterns, seldom in P I ,
and rarely in those with N l patterns (10).

Two physicians, instructed in Wolfe's system of classification of mammographic patterns (9), interpreted the
mammograms. W h e n elements of both P2 and DV
existed, the pattern was usually classified as P2. O n l y a
few p r o m i n e n t ducts resulted in a PI rather than N l
classification.
Epithelial hyperplasias were graded by the method of
Wellings (1). Thoroughness of histopathologic study of
specimens varied with the individual pathologist and
with time. During the course of the study. Dr. Thomas
Cajigas and associates, with the aid of Dr. Wellings, developed a rapid, subgross method of studying serial sections of breast specimens (unpublished), which increased
the incidence of premalignant, in situ, and microinvasive lesions.

In patients whose biopsies had Wolfe P2-DY patterns,
detection of the first cancer occurred at an average age
of 49 years, and the second at age 53.1 n those with N l -PI
patterns, the corresponding ages were 61 and 73. The
reason for this age discrepancy remains unclear, although
it is tempting to speculate that the breasts containing

Results
Forty-five of 162 (27.8%) contralateral biopsies or mastectomies resulted in a diagnosis of malignancy: 33 were
invasive; 12 in situ. Fifty-three patients (33%) had premalignant lesions or atypical epithelial hyperplasia (Wellings grade III [27] or IV [26]). A cancer incidence of
13.6% was f o u n d in those with no palpable or m a m m o graphic suspicion of malignancy. This finding is consistent with the studies reported by Urban and Leis (10).

TABLE I
Contralateral Breast Biopsies
M e t h o d of Detection Correlated w i t h
Cancer Size and Lymph N o d e Metastasis

The size of the cancer and incidence of axillary lymph
node metastasis varied significantly with the method of
detection (Table I). Only 20% of the 20 palpable cancers
were less than 2.0 cm in diameter, and 30% had axillary
metastasis. The five nonpalpable cancers detected by
mammography were earlier cancers and illustrate the
value of mammographic surveillance. Twenty of the 45
cancers, however, were discovered by biopsy in patients
with no palpable or mammographic evidence of malignancy. Of these 20 cancers, 70% were 0.5 cm or less in
diameter, and only two had axillary metastasis. Three
patients with pathological stage I ipsilateral cancers had

Cancer Size
Detection
Method
Palpation

No.

% with

Average

2.0 c m
or<

0.5 cm
or<
5%

nod est
20

2.7 cm

25%

5

20

1.6

8C

20

Biopsy

20t

10

0.5

85

70

TOTALS

45*

20%

1.6 cm

58%

38%

Radiography

30%

*33 invasive and 12 in situ cancers
t A l l 20 nonpalpable and not visible on mammography

22

The Other Breast

TABLE II

prominent ducts and severe dysplasias have been subjected to more virulent a n d / o r greater quantities of carcinogen(s). Patients with a family history of breast cancer
had cancer at an earlier age than the entire group but no
younger than those with P2-DY patterns.

Prophylactic Contralateral Breast Biopsy
Correlated w i t h W o l f e Patterns
Cancers

Epithelial Hyperplasia
Grades (Wellings)

An attempt to correlate cancer bilaterality with multifocal lesions in the first breast failed because of marked
variance among pathologists in searching for additional
lesions. The incidence ranged from 6% to 58%. The latter
figure is more consistent with the incidence recently
reported by Egan (3). Attempts to correlate multicentricity with the Wolfe patterns failed for thesame reason. No
attempt was made to correlatethe incidence of bilaterality with the histological grade or type of the tumor in the
first cancer, nor with the presence or absence of estrogen receptors in the first cancer.

Wolfe

No.

N1-P1

24%

P2-DY

76

Invasive
0%
13

In Situ

IV

111

llor<

12.5%

12.5%

21%

54%

21

33

33
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the classification of dysplasias of the uterus and cervix
made by means of the Pap smear. It is helpful in making
decisions about the management of the disease.
Patients w h o have had cancer of one breast require
constant surveillance. There is scant evidence, however,
that such a procedure actually results in discovering the
second cancer any earlier than the first one. Most
patients in our study had not practiced routine self
breast examination (SBE). In those with palpable cancers,
the patients rarely had yearly mammograms. However,
all twenty of the patients with cancer detected only by
biopsy had had " n e g a t i v e " mammograms within one
year before biopsy. There seems little doubt that SBE,
frequent physical examinations, and screening mammography can discover more cancers and at an earlier
stage. If the patient and physician remain unconcerned,
however, the result too often yields an incurable cancer
in the contralateral breast. Contralateral biopsy at the
time of the mastectomy requires only a small amount of
additional effort, time, and cost; it results in little, if any,
additional morbidity and no mortality. It allows detection of some additional cancers and premalignant lesions
and provides worthwhile information which may well
influence decisions about management of the disease.

Discussion
Many investigators (1-3), including Samhouri, Block, and
Kambouris (10), have documented the multicentric and
bilateral nature of breast cancer. Urban and Leis (11)
have demonstrated that significant numbers of occult
contralateral breast cancers can be detected by routine
contralateral biopsies, and greater numbers by selective
contralateral prophylactic mastectomies. The incidence
of bilaterality is higher than reported in those studies
when cancers evident by palpation or mammography
are included. O u r study and others (10) indicate that the
incidence varies with the method(s) of detection. It also
varies with the size of the specimen, diligence of the
pathologist, and length of follow-up (9).
If epithelial atypia is present in biopsy specimens, the
patient is at a significantly higher risk of developing
invasive cancer (12-14). In this study, eight patients with
these lesions in antecedent biopsy specimens developed malignancies within three years after the biopsy
was performed. Thus far, none of the patients with
epithelial hyperplasia, Wellings grade II or less, have
developed contralateral cancer. These data support the
pathological evidence that severe atypical epithelial
hyperplasia in abnormal terminal ductal lobular units is
premalignant (1,2). It also supports the clinical studies of
others indicating that patients with atypical epithelial
hyperplasia are at considerably higher risk than those
w i t h o u t hyperplasia (12-14). The method of grading used
in this study is similar to that of Black (13). It indicates
whether cellular abnormalities of mammary epithelium
are m i l d , moderate, or severe. In the author's view, it is
somewhat analogous in both method and significance to

In our institution, 65-70% of the patients with prevalent
cancers have P2 or DY mammographic patterns. Over
90% of our false negative mammographic diagnoses also
occur in these patterns. Patients w i t h these patterns are
also more difficult to evaluate by palpation. In this study,
they were f o u n d to have a higher risk of invasive contralateral cancer or premalignant lesions. In the absence of
palpable abnormalities, the locations of prominent ducts
and areas of asymmetry aided considerably in choosing
where to perform the biopsy. In patients w h o had no
palpable abnormalities but diffuse symmetrical prominent ducts or dysplasia, the biopsy was performed in
mirror image locations, or the upper outer quadrant.
In all breast cancer patients except in those with a known
short life expectancy, valuable information can be provided by mammography, knowledgeable interpretation
23
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of the Wolfe parenchymal patterns, contralateral biopsy,
and a diligent search for premalignant and obscure
malignant lesions by an informed and interested pathologist. These procedures all are needed to make logical
decisions about therapy and surveillance. Serial sectioning of the specimen and rapid subgross preparation (or
radiography) of the slices helps considerably in identify-

ing significant lesions. The presence of severe atypical
epithelial hyperplasia in terminal ductal lobular units
puts the patient at a high risk of subsequent invasive
cancer. In such patients, prophylactic mastectomy with
reconstruction seems a logical alternative to constant
surveillance.
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